This announcement is a separate document:
康辰药业：康辰药业关于中药创新药ZY5301临床研究结果荣登《JAMA》子刊的公告
Beijing Konruns Pharmaceutical: Announcement from Beijing Konruns Pharmaceutical on traditional Chinese medicine innovative drug ZY5301 clinical research results being featured in the sub-journal of JAMA.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated